Abstract A 13 year old Greek girl with myasthenia gravis developed widespread muscle paralysis and atrophy after large parenteral doses of corticosteroids (5.48 g methylprednisolone). An electromyogram showed myopathy, creatine kinase concentration below normal, and a muscle biopsy showed severe myopathy with selective loss of the thick filaments (myosin). Previous reports of myopathy associated with large steroid doses have mostly been in patients who were also receiving non-depolarising neuromuscular blocking drugs. This patient is unique in that severe myopathy was associated with neuromuscular blockade caused by antibodies to acetylcholine receptors. The findings in this case suggest that high doses of parenteral corticosteroids in patients with myasthenia gravis may be dangerous and that blocking the neuromuscular junction with drugs or antibodies predisposes skeletal muscles to the injurious effects of corticosteroids.
On arrival she was receiving assisted ventilation. There was bilateral partial ptosis, but a full range of ocular movements, and only mild weakness of facial muscles. She had generalised limb muscle wasting, most severe in the quadriceps and tibialis anterior muscles. There were no fasciculations. She had severe weakness of her arms. She was unable to raise her legs off the bed, and there were no movements of the knees or ankles. All the deep tendon reflexes were absent, except for the triceps jerks, which were evokable with reinforcement. The plantar responses were flexor. There were no sensory abnormalities.
Creatine phosphokinase activity was 31 IU/l (normal 75-200). Electrophysiological studies showed normal sensory and motor conduction. The mean jitter of 10 single fibre pairs was 68-4 ,us, half of them exceeding the normal value of 42 pus, thus confirming the defect in neuromuscular transmission. Concentric needle examination of the left biceps showed a crowded pattern of motor unit recruitment, with motor units up to 0 5 mV often with spiky and polyphasic waveforms suggestive of a primary muscle disease. The concentration of antibody to acetylcholine receptors was strongly positive at 18 900 pg/l (normal <200 pg/l). 4 We conclude from our case that large doses of parenteral corticosteroids should be avoided in myasthenia gravis because of the risk of increasing muscle weakness by inducing an acute myopathy. 
